{"gene":"GSS","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1995,"finding":"The human glutathione synthetase gene (GSS) was mapped to chromosome 20q11.2. Southern blot analysis with a GSS cDNA probe suggested a single GSS gene in the human genome, and somatic cell hybrid and in situ hybridization analyses localized it to subband 20q11.2.","method":"Somatic cell hybrid analysis, in situ hybridization, Southern blotting","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 — direct chromosomal mapping by two orthogonal methods","pmids":["8825653"],"is_preprint":false},{"year":1999,"finding":"The CNC-bZIP transcription factor Nrf1 regulates expression of glutathione synthetase (GSS) and gamma-glutamylcysteine synthetase (gamma-GCS(L)). Fibroblasts from Nrf1 knockout mice showed reduced GSH levels and increased sensitivity to oxidants, demonstrating Nrf1 as a transcriptional regulator of GSS expression.","method":"Nrf1 knockout mouse fibroblasts, gene expression analysis, glutathione quantification, oxidant sensitivity assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout with defined molecular and cellular phenotypes, replicated across multiple assays","pmids":["10601325"],"is_preprint":false},{"year":2003,"finding":"In patients with glutathione synthetase deficiency lacking coding exon mutations, RT-PCR revealed novel splice mutations causing absence of detectable GSS protein (by polyclonal antibody) and severely reduced GSS enzymatic activity in fibroblast lysates, establishing that splice-site mutations are a major disease mechanism.","method":"RT-PCR sequencing, enzyme activity assay in fibroblast lysates, immunoblot with polyclonal antibody","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 — multiple patients, enzymatic and protein-level validation, single lab","pmids":["14635114"],"is_preprint":false},{"year":2019,"finding":"FAT1 oncogene drives cisplatin resistance in oral squamous cell carcinoma partly through upregulation of GSS-mediated glutathione synthesis via the LRP5/WNT2 signaling axis; shFAT1 knockdown simultaneously deregulated LRP5/WNT2 signaling, enhanced GSS-mediated oxidative stress, and re-sensitized resistant cells to cisplatin.","method":"shRNA knockdown, cell viability, invasion/migration assays, Western blotting, signaling pathway analysis","journal":"Cancers","confidence":"Medium","confidence_rationale":"Tier 3 — pathway placement by KD with defined phenotype, single lab, moderate mechanistic follow-up","pmids":["31783581"],"is_preprint":false},{"year":2021,"finding":"Protein-protein interaction analysis revealed that GPX4 exerts its biological role through regulation of a GSS/GSR complex and downstream GGT family proteins; AFC-induced inhibition of this GPX4-GSS/GSR-GGT axis reduced glutathione synthesis and triggered ferroptosis in NSCLC cells.","method":"qPCR, protein-protein interaction analysis, cell proliferation and apoptosis assays, flow cytometry","journal":"International journal of medical sciences","confidence":"Low","confidence_rationale":"Tier 3 — interaction identified by computational PPI analysis, limited direct biochemical validation of GSS complex","pmids":["33746607"],"is_preprint":false},{"year":2022,"finding":"α-Hederin destroys the GSS/GSH/GPX2 axis in NSCLC by downregulating GSS expression, thereby suppressing glutathione synthesis, collapsing the GSH redox system, and inducing ferroptosis and apoptosis in vitro and in vivo.","method":"Proteomics, metabolomics, high-throughput sequencing, in vitro and in vivo cancer models","journal":"Biomedicine & pharmacotherapy","confidence":"Medium","confidence_rationale":"Tier 2 — multi-omic orthogonal methods in single lab establishing GSS as key node in ferroptosis pathway","pmids":["35398749"],"is_preprint":false},{"year":2023,"finding":"Gss is expressed primarily in pachytene spermatocytes, and conditional knockout of Gss in germ cells (using Stra8-Cre) causes age-dependent male infertility via ferroptosis in the testis. In young knockout mice, compensatory GPX4 upregulation prevents ROS accumulation; in aged mice, GPX4 declines and ALOX15 increases, leading to lipid peroxidation and testicular ferroptosis, disrupting meiosis and acrosome formation. Intraperitoneal GSH or ferrostatin-1 rescued fertility.","method":"Conditional Gss knockout (Stra8-Cre), fertility assays, immunofluorescence, ROS/lipid peroxidation assays, ferroptosis inhibitor rescue (GSH, Fer-1), Western blotting","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO with specific cellular phenotype, multiple orthogonal methods, mechanistic rescue experiments","pmids":["38114454"],"is_preprint":false},{"year":2024,"finding":"Two fetal siblings with compound heterozygous GSS variants (missense p.Arg267Gln and a 2.4 kb intragenic deletion causing out-of-frame exon 3 deletion) exhibited severe GSS deficiency with multiple congenital anomalies. RNA-seq showed near-monoallelic expression and NMD of the deletion allele; elevated 5-oxoproline in amniotic fluid confirmed disruption of the gamma-glutamyl cycle.","method":"Genome sequencing, RNA-seq on brain tissue, amniotic fluid metabolite analysis (5-oxoproline measurement)","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 2 — molecular characterization of mutant alleles with functional metabolic readout, single case series","pmids":["39221916"],"is_preprint":false},{"year":2025,"finding":"Age-related DNA methylation-mediated suppression of GSS in bone marrow mesenchymal stem cells (BMSCs) reduces glutathione synthesis and impairs osteoblast differentiation independently of substrate (cysteine) availability, constituting an upstream metabolic lesion in age-related osteoporosis. Exosome-mediated delivery of GSH to aged bone rescued osteogenic function.","method":"DNA methylation analysis, GSS expression analysis in aged BMSCs, cysteine supplementation experiments, CXCR4-exosome GSH delivery in vivo, osteogenesis assays","journal":"Bioactive materials","confidence":"Medium","confidence_rationale":"Tier 2 — epigenetic mechanism identified with functional rescue, single lab","pmids":["41674552"],"is_preprint":false},{"year":2025,"finding":"Metformin inhibits hypertrophic scar fibroblast proliferation and induces ferroptosis by downregulating RRM2, which in turn suppresses GSS expression, impairing glutathione synthesis, indirectly reducing GPX4, and leading to peroxide accumulation (RRM2/GSS/GPX4 axis).","method":"In vitro and in vivo (rabbit ear) fibrosis models, Western blotting, RRM2 knockdown, ferroptosis markers","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 — genetic and pharmacological perturbation with defined pathway placement, in vivo validation","pmids":["41619824"],"is_preprint":false},{"year":2025,"finding":"LncRNA HCG18 acts as a ceRNA to sponge miR-30a-5p, increasing RRM2 expression, which directly upregulates GSS to increase glutathione synthesis and confer ferroptosis resistance in hepatocellular carcinoma.","method":"Colony formation assay, xenograft mouse model, luciferase reporter, RRM2 overexpression/knockdown, GSS expression analysis","journal":"International journal of biological sciences","confidence":"Medium","confidence_rationale":"Tier 2-3 — ceRNA axis validated in vitro and in vivo, RRM2-GSS link demonstrated by direct regulation experiment","pmids":["40303288"],"is_preprint":false}],"current_model":"GSS (glutathione synthetase) catalyzes the final ATP-dependent step in glutathione biosynthesis; its transcription is regulated by the CNC-bZIP factor Nrf1 and by age-related DNA methylation, and its expression is controlled upstream by RRM2 (via the HCG18/miR-30a-5p/RRM2 axis); GSS-dependent GSH production is essential for male fertility (protecting spermatocytes from ferroptosis via a GPX4-compensatory mechanism), bone homeostasis, and resistance to ferroptosis in multiple cell types, with loss-of-function mutations disrupting the gamma-glutamyl cycle and causing hemolytic anemia, 5-oxoprolinuria, and developmental defects."},"narrative":{"teleology":[{"year":1995,"claim":"Establishing the genomic context of GSS: mapping to a single-copy gene at chromosome 20q11.2 set the stage for mutation analysis in glutathione synthetase deficiency.","evidence":"Somatic cell hybrid and in situ hybridization with a GSS cDNA probe","pmids":["8825653"],"confidence":"High","gaps":["Promoter and regulatory elements of the GSS locus were not characterized","No disease-causing mutations had yet been mapped to this locus"]},{"year":1999,"claim":"Identifying the first transcriptional regulator of GSS: Nrf1 knockout fibroblasts showed reduced GSS expression, depleted GSH, and heightened oxidant sensitivity, establishing Nrf1 as a master upstream activator of the glutathione biosynthetic pathway.","evidence":"Nrf1-null mouse fibroblasts with gene expression analysis, GSH quantification, and oxidant challenge","pmids":["10601325"],"confidence":"High","gaps":["Whether Nrf1 binds the GSS promoter directly or acts through intermediary factors was not resolved","Contribution of Nrf2 versus Nrf1 to GSS regulation was not delineated"]},{"year":2003,"claim":"Defining splice-site mutations as a major disease mechanism: patients without coding-exon mutations were shown to harbor splice defects that ablated GSS protein and enzymatic activity, broadening the mutational spectrum of glutathione synthetase deficiency.","evidence":"RT-PCR, immunoblot, and enzyme activity assay in patient fibroblasts","pmids":["14635114"],"confidence":"Medium","gaps":["Genotype–phenotype correlations across the full spectrum of GSS mutations were not established","No structural explanation for residual activity in partial-loss alleles"]},{"year":2022,"claim":"Placing GSS as a central node in ferroptosis resistance: multiple studies in cancer cells showed that pharmacological or genetic suppression of GSS collapses the GSH/GPX axis and induces ferroptosis, linking GSS activity directly to lipid peroxide detoxification.","evidence":"Multi-omic profiling (proteomics, metabolomics, sequencing) in NSCLC models treated with α-hederin; pathway analysis of GPX4–GSS/GSR–GGT axis","pmids":["35398749","33746607"],"confidence":"Medium","gaps":["The GPX4–GSS/GSR complex interaction (PMID:33746607) relied on computational PPI analysis without direct biochemical validation","Whether GSS enzymatic activity or protein scaffolding drives the ferroptosis phenotype was not distinguished"]},{"year":2023,"claim":"Demonstrating an essential, non-redundant role of GSS in male germ cells: conditional Gss knockout in spermatocytes caused age-dependent ferroptosis, with early GPX4 compensation eventually failing, proving that GSS-derived GSH is indispensable for spermatogenesis and acrosome biogenesis.","evidence":"Conditional knockout (Stra8-Cre) in mice with fertility testing, lipid peroxidation assays, and rescue by exogenous GSH and ferrostatin-1","pmids":["38114454"],"confidence":"High","gaps":["Mechanism by which GPX4 is initially upregulated to compensate for GSS loss is unknown","Whether somatic Sertoli-cell GSH contributes to paracrine germ-cell protection was not tested"]},{"year":2024,"claim":"Expanding the clinical genetics of severe GSS deficiency: compound heterozygous fetal cases with a novel intragenic deletion showed near-monoallelic expression due to NMD and confirmed 5-oxoproline accumulation as a prenatal biomarker of γ-glutamyl cycle disruption.","evidence":"Genome sequencing, RNA-seq on fetal brain, amniotic fluid metabolite measurement","pmids":["39221916"],"confidence":"Medium","gaps":["Structural consequences of the p.Arg267Gln missense on enzyme stability or dimerization were not modeled","Only two siblings studied; broader genotype–phenotype correlations remain limited"]},{"year":2025,"claim":"Defining upstream regulatory axes that converge on GSS: RRM2 was identified as a direct positive regulator of GSS expression, itself modulated by the lncRNA HCG18/miR-30a-5p ceRNA circuit (in HCC) and by metformin-mediated suppression (in fibroblasts), positioning GSS as the effector node linking proliferative signaling to glutathione-dependent ferroptosis resistance.","evidence":"Luciferase reporter, RRM2 overexpression/knockdown, xenograft models, and in vivo rabbit ear fibrosis models","pmids":["40303288","41619824"],"confidence":"Medium","gaps":["Whether RRM2 regulates GSS transcriptionally or post-transcriptionally was not fully resolved","Independence of the RRM2–GSS axis from Nrf1/Nrf2 signaling is untested"]},{"year":2025,"claim":"Linking epigenetic silencing of GSS to age-related bone loss: DNA methylation-mediated GSS suppression in aged BMSCs impaired osteoblast differentiation independently of cysteine availability, identifying GSS as an upstream metabolic lesion in osteoporosis.","evidence":"DNA methylation and expression analysis in aged BMSCs, cysteine supplementation controls, CXCR4-exosome GSH delivery rescue in vivo","pmids":["41674552"],"confidence":"Medium","gaps":["Specific CpG sites mediating age-dependent GSS silencing were not mapped","Whether DNMT inhibitors can restore GSS expression and bone formation in vivo is untested"]},{"year":null,"claim":"Key unresolved questions include the structural basis of disease-causing GSS mutations, the relative contributions of Nrf1 versus Nrf2 versus RRM2 to tissue-specific GSS regulation, and whether GSS has non-catalytic roles (e.g. protein scaffolding) in ferroptosis signaling complexes.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of human GSS with bound substrates or disease-associated mutant forms","Tissue-specific transcriptional regulation hierarchy (Nrf1 vs Nrf2 vs RRM2) not systematically compared","Potential non-enzymatic functions of GSS protein remain unexplored"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016874","term_label":"ligase activity","supporting_discovery_ids":[1,2,5,6,7,8]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[6]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,5,6,8,9,10]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[5,6,9]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[1,8]}],"complexes":[],"partners":["NRF1","GPX4","RRM2","GSR"],"other_free_text":[]},"mechanistic_narrative":"Glutathione synthetase (GSS) catalyzes the ATP-dependent ligation of γ-glutamylcysteine and glycine in the final step of de novo glutathione (GSH) biosynthesis, and its activity is rate-limiting for cellular redox homeostasis, ferroptosis resistance, and the γ-glutamyl cycle. GSS transcription is positively regulated by the CNC-bZIP factor Nrf1 [PMID:10601325] and by RRM2 (itself controlled via the HCG18/miR-30a-5p ceRNA axis) [PMID:40303288, PMID:41619824], and is suppressed by age-related DNA methylation in bone marrow mesenchymal stem cells, contributing to impaired osteogenesis [PMID:41674552]. Conditional germ-cell knockout in mice demonstrates that GSS-derived GSH is essential for male fertility, with loss triggering age-dependent testicular ferroptosis that is initially compensated by GPX4 upregulation but ultimately leads to lipid peroxidation, meiotic arrest, and acrosome defects [PMID:38114454]. Loss-of-function mutations in humans—including splice-site and intragenic deletions—cause glutathione synthetase deficiency with 5-oxoprolinuria, hemolytic anemia, and severe congenital anomalies [PMID:14635114, PMID:39221916]."},"prefetch_data":{"uniprot":{"accession":"P48637","full_name":"Glutathione synthetase","aliases":["Glutathione synthase"],"length_aa":474,"mass_kda":52.4,"function":"Catalyzes the production of glutathione from gamma-glutamylcysteine and glycine in an ATP-dependent manner (PubMed:7646467, PubMed:9215686). Glutathione (gamma-glutamylcysteinylglycine, GSH) is the most abundant intracellular thiol in living aerobic cells and is required for numerous processes including the protection of cells against oxidative damage, amino acid transport, the detoxification of foreign compounds, the maintenance of protein sulfhydryl groups in a reduced state and acts as a cofactor for a number of enzymes (PubMed:10369661). Participates in ophthalmate biosynthesis in hepatocytes (By similarity)","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P48637/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GSS","classification":"Not Classified","n_dependent_lines":22,"n_total_lines":1208,"dependency_fraction":0.018211920529801324},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GSS","total_profiled":1310},"omim":[{"mim_id":"614243","title":"5-@OXOPROLINASE (ATP-HYDROLYZING); OPLAH","url":"https://www.omim.org/entry/614243"},{"mim_id":"612342","title":"GAMMA-GLUTAMYLTRANSFERASE 7; GGT7","url":"https://www.omim.org/entry/612342"},{"mim_id":"603863","title":"RING FINGER PROTEIN 7; RNF7","url":"https://www.omim.org/entry/603863"},{"mim_id":"601002","title":"GLUTATHIONE SYNTHETASE; GSS","url":"https://www.omim.org/entry/601002"},{"mim_id":"266130","title":"GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD","url":"https://www.omim.org/entry/266130"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GSS"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P48637","domains":[{"cath_id":"-","chopping":"5-336_401-472","consensus_level":"medium","plddt":95.379,"start":5,"end":472},{"cath_id":"3.30.1490.50","chopping":"337-400","consensus_level":"medium","plddt":93.8878,"start":337,"end":400}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P48637","model_url":"https://alphafold.ebi.ac.uk/files/AF-P48637-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P48637-F1-predicted_aligned_error_v6.png","plddt_mean":94.94},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GSS","jax_strain_url":"https://www.jax.org/strain/search?query=GSS"},"sequence":{"accession":"P48637","fasta_url":"https://rest.uniprot.org/uniprotkb/P48637.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P48637/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P48637"}},"corpus_meta":[{"pmid":"10601325","id":"PMC_10601325","title":"The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10601325","citation_count":156,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15962001","id":"PMC_15962001","title":"Immunodetection of disease-associated mutant PrP, which accelerates disease in GSS transgenic mice.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15962001","citation_count":123,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10656806","id":"PMC_10656806","title":"A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice.","date":"2000","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10656806","citation_count":115,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22043907","id":"PMC_22043907","title":"Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome.","date":"2011","source":"Journal of toxicology and environmental health. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/22043907","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33746607","id":"PMC_33746607","title":"Ammonium Ferric Citrate induced Ferroptosis in Non-Small-Cell Lung Carcinoma through the inhibition of GPX4-GSS/GSR-GGT axis activity.","date":"2021","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33746607","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18038270","id":"PMC_18038270","title":"Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro.","date":"2007","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18038270","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12814912","id":"PMC_12814912","title":"Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients.","date":"2003","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12814912","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38114454","id":"PMC_38114454","title":"Gss deficiency causes age-related fertility impairment via ROS-triggered ferroptosis in the testes of mice.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38114454","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31783581","id":"PMC_31783581","title":"Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5/WNT2/GSS Signaling Axis in Oral Squamous Cell Carcinoma.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31783581","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35398749","id":"PMC_35398749","title":"Regulatory mechanism of α-hederin upon cisplatin sensibility in NSCLC at safe dose by destroying GSS/GSH/GPX2 axis-mediated glutathione oxidation-reduction system.","date":"2022","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/35398749","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20547632","id":"PMC_20547632","title":"The first case of protease-sensitive prionopathy (PSPr) in The Netherlands: a patient with an unusual GSS-like clinical phenotype.","date":"2010","source":"Journal of neurology, neurosurgery, and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/20547632","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28934494","id":"PMC_28934494","title":"Derivatives of Bst-like Gss-polymerase with improved processivity and inhibitor tolerance.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28934494","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1684758","id":"PMC_1684758","title":"The transmissible amyloidoses: genetical control of spontaneous generation of infectious amyloid proteins by nucleation of configurational change in host precursors: kuru-CJD-GSS-scrapie-BSE.","date":"1991","source":"European journal of epidemiology","url":"https://pubmed.ncbi.nlm.nih.gov/1684758","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26135918","id":"PMC_26135918","title":"Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS.","date":"2015","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/26135918","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8825653","id":"PMC_8825653","title":"The gene encoding human glutathione synthetase (GSS) maps to the long arm of chromosome 20 at band 11.2.","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8825653","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22965875","id":"PMC_22965875","title":"Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders.","date":"2012","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22965875","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17368456","id":"PMC_17368456","title":"Preliminary study on the receptor of gonad-stimulating substance (GSS) as a gonadotropin of starfish.","date":"2007","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17368456","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29338055","id":"PMC_29338055","title":"A novel Gerstmann-Sträussler-Scheinker disease mutation defines a precursor for amyloidogenic 8 kDa PrP fragments and reveals N-terminal structural changes shared by other GSS alleles.","date":"2018","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/29338055","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23299511","id":"PMC_23299511","title":"Identification of miRNA encoded by Jatropha curcas from EST and GSS.","date":"2013","source":"Plant signaling & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/23299511","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14635114","id":"PMC_14635114","title":"Diagnostics in patients with glutathione synthetase deficiency but without mutations in the exons of the GSS gene.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/14635114","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32516343","id":"PMC_32516343","title":"Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS.","date":"2020","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/32516343","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31907562","id":"PMC_31907562","title":"SNP markers for early identification of high molecular weight glutenin subunits (HMW-GSs) in bread wheat.","date":"2020","source":"TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik","url":"https://pubmed.ncbi.nlm.nih.gov/31907562","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22134181","id":"PMC_22134181","title":"Participation of Gs-proteins in the action of relaxin-like gonad-stimulating substance (GSS) for 1-methyladenine production in starfish ovarian follicle cells.","date":"2011","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22134181","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32082076","id":"PMC_32082076","title":"Suppressive Effects of GSS on Lipopolysaccharide-Induced Endothelial Cell Injury and ALI via TNF-α and IL-6.","date":"2019","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/32082076","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20829230","id":"PMC_20829230","title":"A Drosophila model of GSS syndrome suggests defects in active zones are responsible for pathogenesis of GSS syndrome.","date":"2010","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20829230","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21295575","id":"PMC_21295575","title":"Hormonal action of relaxin-like gonad-stimulating substance (GSS) on starfish ovaries in growing and fully grown states.","date":"2011","source":"General and comparative endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21295575","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29340523","id":"PMC_29340523","title":"A case of severe glutathione synthetase deficiency with novel GSS mutations.","date":"2018","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/29340523","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18782453","id":"PMC_18782453","title":"ReRep: computational detection of repetitive sequences in genome survey sequences (GSS).","date":"2008","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/18782453","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7607672","id":"PMC_7607672","title":"High-resolution physical mapping of a 250-kb region of human chromosome 11q24 by genomic sequence sampling (GSS).","date":"1995","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/7607672","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21214405","id":"PMC_21214405","title":"Autophagy contributes to widespread neuronal degeneration in hamsters infected with the Echigo-1 strain of Creutzfeldt-Jakob disease and mice infected with the Fujisaki strain of Gerstmann-Sträussler-Scheinker (GSS) syndrome.","date":"2011","source":"Ultrastructural pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21214405","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1687809","id":"PMC_1687809","title":"[Recent advances in the research of Creutzfeldt-Jakob disease (CJD) and Gerstmann-Strüssler syndrome (GSS)].","date":"1991","source":"Rinsho shinkeigaku = Clinical neurology","url":"https://pubmed.ncbi.nlm.nih.gov/1687809","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23054223","id":"PMC_23054223","title":"Characterization of HMW-GSs and their gene inaction in tetraploid wheat.","date":"2012","source":"Genetica","url":"https://pubmed.ncbi.nlm.nih.gov/23054223","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35216291","id":"PMC_35216291","title":"Effects of Nitrogen Fertilizer on Quality Characteristics of Wheat with the Absence of Different Individual High-Molecular-Weight Glutenin Subunits (HMW-GSs).","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35216291","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31189938","id":"PMC_31189938","title":"\"Dual Disease\" TgAD/GSS mice exhibit enhanced Alzheimer's disease pathology and reveal PrPC-dependent secretion of Aβ.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31189938","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11771163","id":"PMC_11771163","title":"[A case of Gerstmann-Sträussler-Scheinker syndrome (GSS) with late onset--a haplotype analysis of Glu219Lys polymorphism in PrP gene].","date":"2001","source":"Rinsho shinkeigaku = Clinical neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11771163","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36397183","id":"PMC_36397183","title":"Effects of HMW-GSs at Glu-B1 locus on starch-protein interaction and starch digestibility during thermomechanical processing of wheat dough.","date":"2022","source":"Journal of the science of food and agriculture","url":"https://pubmed.ncbi.nlm.nih.gov/36397183","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40303288","id":"PMC_40303288","title":"Targeting HCG18 counteracts ferroptosis resistance via blocking the miR-30a-5p/RRM2/GSS pathway in hepatocellular carcinoma.","date":"2025","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40303288","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32256010","id":"PMC_32256010","title":"Analysis of microRNAs and their targets from onion (Allium cepa) using genome survey sequences (GSS) and expressed sequence tags (ESTs).","date":"2019","source":"Bioinformation","url":"https://pubmed.ncbi.nlm.nih.gov/32256010","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31890235","id":"PMC_31890235","title":"A case of Gerstmann-Straussler-Scheinker (GSS) disease with supranuclear gaze palsy.","date":"2019","source":"Journal of clinical movement disorders","url":"https://pubmed.ncbi.nlm.nih.gov/31890235","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27999069","id":"PMC_27999069","title":"Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.","date":"2016","source":"The Journal of antimicrobial chemotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/27999069","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38754351","id":"PMC_38754351","title":"Dynamic behaviors of protein and water associated with fresh noodle quality during processing based on different HMW-GSs at Glu-D1.","date":"2024","source":"Food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38754351","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37281473","id":"PMC_37281473","title":"Absence of 1-Methyladenine Production in Follicle Cells Obtained from Starfish Ovaries in the Post-Spawning Season: (starfish follicle celis/1-MeAde/GSS/cAMP/post-spawning season).","date":"1991","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/37281473","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36673453","id":"PMC_36673453","title":"Transcriptome and Proteome Analysis Revealed the Influence of High-Molecular-Weight Glutenin Subunits (HMW-GSs) Deficiency on Expression of Storage Substances and the Potential Regulatory Mechanism of HMW-GSs.","date":"2023","source":"Foods (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36673453","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25397488","id":"PMC_25397488","title":"Improved therapy-success prediction with GSS estimated from clinical HIV-1 sequences.","date":"2014","source":"Journal of the International AIDS Society","url":"https://pubmed.ncbi.nlm.nih.gov/25397488","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18409537","id":"PMC_18409537","title":"[Case of Gerstmann-Sträussler-Scheinker syndrome (GSS-P102L) mimicking variant Creurtzfeldt-Jakob disease in clinical manifestation and MRI findings].","date":"2008","source":"Rinsho shinkeigaku = Clinical neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18409537","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16768100","id":"PMC_16768100","title":"[Patient with Gerstmann-Striussler-Scheinker syndrome (GSS P102L) presenting high intensity lesions in the cerebral cortex on diffusion weighted MRI].","date":"2006","source":"Rinsho shinkeigaku = Clinical neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16768100","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21997095","id":"PMC_21997095","title":"Design studies for ASIC implementations of 28 GS/s optical QPSK- and 16-QAM-OFDM transceivers.","date":"2011","source":"Optics express","url":"https://pubmed.ncbi.nlm.nih.gov/21997095","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38193206","id":"PMC_38193206","title":"HMW-GSs 1Dx3+1Dy12 contribute to a suitable wheat gluten strength that confers superior Chinese steamed bread quality.","date":"2024","source":"Journal of food science","url":"https://pubmed.ncbi.nlm.nih.gov/38193206","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41674552","id":"PMC_41674552","title":"Age-related GSS promoter methylation in BMSCs drives osteoporosis and the reversal by targeted GSH delivery.","date":"2026","source":"Bioactive materials","url":"https://pubmed.ncbi.nlm.nih.gov/41674552","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21364775","id":"PMC_21364775","title":"Insights from the GC content analysis of 76genome survey sequences (GSS) from Elaeisoleifera.","date":"2010","source":"Bioinformation","url":"https://pubmed.ncbi.nlm.nih.gov/21364775","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37281076","id":"PMC_37281076","title":"Effect of Ca2+ -free Seawater Treatment on 1-Methyladenine Production in Starfish Ovarian Follicle Cells: (starfish follicle cells/1-MeAde/GSS/cAMP/Ca2 +-free seawater).","date":"1994","source":"Development, growth & differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/37281076","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22211659","id":"PMC_22211659","title":"Does GSS still maintain relevance on HAART outcome after the introduction of newest active antiretroviral drugs? 48 weeks results.","date":"2011","source":"Current HIV research","url":"https://pubmed.ncbi.nlm.nih.gov/22211659","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9103904","id":"PMC_9103904","title":"[Creutzfeldt-Jakob disease(CJD) and Gerstmann-Sträussler-Scheinker syndrome(GSS)].","date":"1997","source":"Nihon rinsho. Japanese journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/9103904","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39221916","id":"PMC_39221916","title":"Multiple congenital anomalies in two fetuses with glutathione-synthetase deficit (GSS).","date":"2024","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39221916","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41619824","id":"PMC_41619824","title":"Metformin targets RRM2/GSS/GPX4 axis to induce fibroblast ferroptosis: A foreground strategy against hypertrophic scarring.","date":"2026","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41619824","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.11.18.689143","title":"Impact of Cell Size, Light Wavelengths, and Intensities on Growth, Oxygen Production, and Consumption Rates of  <i>Chromochloris zofingiensis</i>  and  <i>Haematococcus lacustris</i>","date":"2025-11-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.18.689143","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.07.14.664451","title":"Beyond Threat: Changes in Visuocortical Engagement and Oscillatory Brain Activity during Non-Aversive Associative Learning","date":"2025-07-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.14.664451","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.30.646185","title":"Mosquito Sex Separation using Complementation of Selectable Traits and Engineered Neo-Sex Chromosomes","date":"2025-03-31","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.30.646185","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.07.27.667006","title":"A high-quality bread wheat genome unravels adaptive evolution of wheat end-use quality","date":"2025-07-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.27.667006","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.01.21.25320913","title":"VR-based Gamma Sensory Stimulation: A feasibility study","date":"2025-01-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.21.25320913","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.04.22.650062","title":"CRISPR/Cas9-mediated mutagenesis of the <i>white-eye</i> gene in the tephritid pest <i>Bactrocera zonata</i>","date":"2025-04-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.22.650062","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.03.31.25324988","title":"An Analysis of household catastrophic health expenditure and food insecurity in Ghana","date":"2025-04-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.31.25324988","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.01.06.630177","title":"Assessing Garmin’s Stress Level Score Against Heart Rate Variability Measurements","date":"2025-01-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.06.630177","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.05.22.595429","title":"Quantifying Population-level Neural Tuning Functions Using Ricker Wavelets and the Bayesian Bootstrap","date":"2024-05-23","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.22.595429","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26871627","id":"PMC_26871627","title":"The Cellular Phase of Alzheimer's Disease.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26871627","citation_count":1446,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17192785","id":"PMC_17192785","title":"Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.","date":"2007","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17192785","citation_count":1399,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19242475","id":"PMC_19242475","title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.","date":"2009","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/19242475","citation_count":1272,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11283320","id":"PMC_11283320","title":"Prion diseases of humans and animals: their causes and molecular basis.","date":"2001","source":"Annual review of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11283320","citation_count":1018,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10618385","id":"PMC_10618385","title":"NMR solution structure of the human prion protein.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10618385","citation_count":878,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24857020","id":"PMC_24857020","title":"Distinct tau prion strains propagate in cells and mice and define different tauopathies.","date":"2014","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/24857020","citation_count":790,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2564168","id":"PMC_2564168","title":"Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome.","date":"1989","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/2564168","citation_count":728,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1677164","id":"PMC_1677164","title":"Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease.","date":"1991","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/1677164","citation_count":713,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10988071","id":"PMC_10988071","title":"Signal transduction through prion protein.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10988071","citation_count":626,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16713569","id":"PMC_16713569","title":"A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713569","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1439789","id":"PMC_1439789","title":"Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism.","date":"1992","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/1439789","citation_count":568,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22820466","id":"PMC_22820466","title":"Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.","date":"2012","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22820466","citation_count":543,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1346338","id":"PMC_1346338","title":"Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene.","date":"1992","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/1346338","citation_count":480,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24012003","id":"PMC_24012003","title":"Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.","date":"2013","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/24012003","citation_count":480,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8962161","id":"PMC_8962161","title":"Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8962161","citation_count":451,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7642585","id":"PMC_7642585","title":"Truncated forms of the human prion protein in normal brain and in prion diseases.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7642585","citation_count":450,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12621436","id":"PMC_12621436","title":"Monoclonal antibodies inhibit prion replication and delay the development of prion disease.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12621436","citation_count":383,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12093732","id":"PMC_12093732","title":"Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12093732","citation_count":336,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17500595","id":"PMC_17500595","title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration.","date":"2007","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17500595","citation_count":325,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16187142","id":"PMC_16187142","title":"Genetic prion disease: the EUROCJD experience.","date":"2005","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16187142","citation_count":322,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11900542","id":"PMC_11900542","title":"Molecular features of the copper binding sites in the octarepeat domain of the prion protein.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11900542","citation_count":315,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3755672","id":"PMC_3755672","title":"Molecular cloning of a human prion protein cDNA.","date":"1986","source":"DNA (Mary Ann Liebert, Inc.)","url":"https://pubmed.ncbi.nlm.nih.gov/3755672","citation_count":311,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"1683708","id":"PMC_1683708","title":"Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene.","date":"1991","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1683708","citation_count":297,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":32316,"output_tokens":2642,"usd":0.068289},"stage2":{"model":"claude-opus-4-6","input_tokens":5983,"output_tokens":2411,"usd":0.135285},"total_usd":0.432373,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":45488,"output_tokens":2936,"usd":0.090252},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6153,"output_tokens":2464,"usd":0.138547}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"The human glutathione synthetase gene (GSS) is a single-copy gene located on chromosome 20q11.2, as determined by Southern blot analysis with GSS cDNA and in situ hybridization using somatic cell hybrids.\",\n      \"method\": \"Somatic cell hybrid analysis, in situ hybridization, Southern blotting\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal mapping methods (somatic cell hybrids + in situ hybridization) in a single study\",\n      \"pmids\": [\"8825653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The transcription factor Nrf1 regulates expression of GSS (glutathione synthetase) and gamma-GCS(L), and Nrf1 null fibroblasts show reduced glutathione levels and enhanced oxidant sensitivity, placing Nrf1 upstream of GSS in the antioxidant response element pathway.\",\n      \"method\": \"Nrf1 knockout mouse fibroblasts, glutathione measurement, oxidant sensitivity assay, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function (knockout) with defined biochemical and cellular phenotype, multiple readouts\",\n      \"pmids\": [\"10601325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In patients with glutathione synthetase deficiency lacking coding-region mutations, RT-PCR revealed splice mutations in the GSS gene that abolish detectable GSS protein (by polyclonal antibody) and severely reduce enzyme activity in fibroblast lysates, demonstrating that splice-site mutations are a mechanism of GSS loss of function.\",\n      \"method\": \"RT-PCR sequencing, enzyme activity assay, immunoblotting with polyclonal anti-GSS antibody, cultured fibroblasts\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (RT-PCR, enzyme activity, immunoblot) in a single study; single lab\",\n      \"pmids\": [\"14635114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GSS (glutathione synthetase) is required for resistance to ferroptosis in spermatocytes: conditional knockout of Gss in germ cells (Stra8-Cre) leads to age-dependent accumulation of ROS, lipid peroxidation, and ferroptosis in testes, with meiosis disruption and acrosome heterotopia; young knockout mice are protected by compensatory GPX4 upregulation, while aged mice show GPX4 decline and ALOX15 increase. Ferroptotic injury is rescued by GSH or ferrostatin-1 injection.\",\n      \"method\": \"Conditional knockout mouse (Stra8-Cre/Gss), ROS measurement, lipid peroxidation assay, ferroptosis markers (GPX4, ALOX15), histology, sperm morphology analysis, rescue with GSH and Fer-1\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — clean conditional KO with defined cellular phenotype, multiple orthogonal mechanistic readouts, pharmacological rescue\",\n      \"pmids\": [\"38114454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GSS functions within a GPX4–GSS/GSR–GGT axis to maintain glutathione metabolism; protein-protein interaction analysis showed GSS and GSR form a complex that is regulated downstream of GPX4, and AFC-induced reduction in GSS expression impairs glutathione biosynthesis and sensitizes NSCLC cells to ferroptosis.\",\n      \"method\": \"Protein-protein interaction (PPI) network analysis, qPCR, cell proliferation and ferroptosis assays in NSCLC cell lines\",\n      \"journal\": \"International journal of medical sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3–4 — PPI analysis is computational/indirect; cellular assays lack direct biochemical validation of complex\",\n      \"pmids\": [\"33746607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"α-hederin destroys the GSS/GSH/GPX2 glutathione redox axis by downregulating GSS and GPX2 expression, suppressing GSH synthesis, and thereby inducing ferroptosis and apoptosis in NSCLC cells; confirmed by proteomics, metabolomics, and high-throughput sequencing.\",\n      \"method\": \"Proteomics, metabolomics, high-throughput sequencing, in vitro and in vivo NSCLC models\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal omics methods in single lab; mechanistic axis defined though not biochemically reconstituted\",\n      \"pmids\": [\"35398749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Age-related DNA methylation of the GSS promoter in bone marrow mesenchymal stem cells (BMSCs) suppresses GSS expression and reduces endogenous GSH synthesis, impairing osteoblast differentiation and causing osteoporosis; cysteine supplementation fails to rescue GSH synthesis, demonstrating GSS activity (not substrate) is the limiting step; targeted GSH delivery via CXCR4-enriched exosomes rescues osteogenesis.\",\n      \"method\": \"DNA methylation analysis of GSS promoter, BMSC culture, osteogenic differentiation assay, GSH measurement, cysteine supplementation, exosome-mediated GSH delivery in aged mouse model\",\n      \"journal\": \"Bioactive materials\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional loss-of-function (epigenetic) with biochemical readout and rescue; single lab\",\n      \"pmids\": [\"41674552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"RRM2 directly regulates GSS expression; metformin downregulates RRM2, which suppresses GSS and GSH synthesis, indirectly reducing GPX4 and triggering ferroptosis in hypertrophic scar fibroblasts, establishing the RRM2/GSS/GPX4 signaling axis.\",\n      \"method\": \"In vitro and in vivo (rabbit ear model) experiments, gene knockdown/overexpression, GPX4/GSS/GSH measurement, ferroptosis assays\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic axis defined with multiple readouts in vitro and in vivo; single lab\",\n      \"pmids\": [\"41619824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Compound heterozygous mutations in GSS (c.738dupG causing frameshift, and an exon 3 repetitive insertion) abolish GSS enzyme activity and protein detectability, causing neonatal glutathione synthetase deficiency with 5-oxoprolinuria, metabolic acidosis, and hemolytic anemia.\",\n      \"method\": \"DNA sequencing of GSS gene, enzyme activity assay, clinical biochemistry (5-oxoproline measurement)\",\n      \"journal\": \"Brazilian journal of medical and biological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and enzymatic confirmation in patient-derived material; single case\",\n      \"pmids\": [\"29340523\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Two GSS variants (missense p.Arg267Gln and a 2.4 kb intragenic deletion removing exon 3 by NMD) cause glutathione synthetase deficiency with elevated amniotic fluid 5-oxoproline, confirming disruption of the gamma-glutamyl cycle; RNA-seq showed near-monoallelic expression of the missense allele, indicating NMD of the deletion allele.\",\n      \"method\": \"Genome sequencing, RNA-seq on fetal brain tissue, amniotic fluid 5-oxoproline measurement, NMD analysis\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-omic genetic/biochemical characterization in fetal tissue; mechanistic confirmation via NMD and metabolite\",\n      \"pmids\": [\"39221916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"lncRNA HCG18 competitively binds miR-30a-5p to upregulate RRM2, which directly regulates GSS to increase GSH synthesis, thereby conferring ferroptosis resistance in hepatocellular carcinoma; silencing HCG18 reduces RRM2/GSS/GSH and sensitizes cells to ferroptosis.\",\n      \"method\": \"Colony formation assay, luciferase reporter assay (implied by competitive binding), gene knockdown/overexpression, in vivo xenograft, GSH and ferroptosis marker measurement\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional axis validated in vitro and in vivo but RRM2→GSS direct regulation relies on expression correlation; single lab\",\n      \"pmids\": [\"40303288\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GSS (glutathione synthetase) catalyzes the final step of glutathione (GSH) biosynthesis; its expression is transcriptionally regulated by Nrf1 via the antioxidant response element, and epigenetically by promoter DNA methylation in aging; GSS activity is rate-limiting for GSH synthesis (not substrate availability), and loss of GSS triggers ROS accumulation, lipid peroxidation, and ferroptosis in germ cells and other cell types, with GSS positioned downstream of RRM2 and upstream of GPX4 in a ferroptosis-regulatory axis.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI need to classify each paper as KEEP (about human GSS = Glutathione Synthetase gene) or EXCLUDE (alias collision or off-target).\n\n**Classification:**\n\n- Papers about Glutathione Synthetase (GSS gene): KEEP → [1], [8], [9], [10], [15], [20], [27], [49], [54], [55], [37]\n- Papers about Gerstmann-Sträussler-Scheinker syndrome (GSS = disease acronym, about PRNP): EXCLUDE (alias collision)\n- Papers about starfish Gonad-Stimulating Substance (GSS): EXCLUDE (symbol collision, invertebrate hormone)\n- Papers about High Molecular Weight Glutenin Subunits (HMW-GSs): EXCLUDE (wheat protein)\n- Papers about Genotypic Susceptibility Score (GSS): EXCLUDE (HIV drug resistance score)\n- Papers about Genome Survey Sequences (GSS): EXCLUDE\n- Papers about Gamma Sensory Stimulation (GSS): EXCLUDE\n- Papers about Genetic Sexing Strains (GSS): EXCLUDE\n- Papers about Generalization Stimuli (GSs): EXCLUDE\n- Other off-target papers: EXCLUDE\n\n**KEEP papers:** [1], [8], [9], [10], [15], [20], [27], [37], [49], [54], [55]\n\nNow extracting mechanistic discoveries:\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"The human glutathione synthetase gene (GSS) was mapped to chromosome 20q11.2. Southern blot analysis with a GSS cDNA probe suggested a single GSS gene in the human genome, and somatic cell hybrid and in situ hybridization analyses localized it to subband 20q11.2.\",\n      \"method\": \"Somatic cell hybrid analysis, in situ hybridization, Southern blotting\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct chromosomal mapping by two orthogonal methods\",\n      \"pmids\": [\"8825653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The CNC-bZIP transcription factor Nrf1 regulates expression of glutathione synthetase (GSS) and gamma-glutamylcysteine synthetase (gamma-GCS(L)). Fibroblasts from Nrf1 knockout mice showed reduced GSH levels and increased sensitivity to oxidants, demonstrating Nrf1 as a transcriptional regulator of GSS expression.\",\n      \"method\": \"Nrf1 knockout mouse fibroblasts, gene expression analysis, glutathione quantification, oxidant sensitivity assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with defined molecular and cellular phenotypes, replicated across multiple assays\",\n      \"pmids\": [\"10601325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In patients with glutathione synthetase deficiency lacking coding exon mutations, RT-PCR revealed novel splice mutations causing absence of detectable GSS protein (by polyclonal antibody) and severely reduced GSS enzymatic activity in fibroblast lysates, establishing that splice-site mutations are a major disease mechanism.\",\n      \"method\": \"RT-PCR sequencing, enzyme activity assay in fibroblast lysates, immunoblot with polyclonal antibody\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple patients, enzymatic and protein-level validation, single lab\",\n      \"pmids\": [\"14635114\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"FAT1 oncogene drives cisplatin resistance in oral squamous cell carcinoma partly through upregulation of GSS-mediated glutathione synthesis via the LRP5/WNT2 signaling axis; shFAT1 knockdown simultaneously deregulated LRP5/WNT2 signaling, enhanced GSS-mediated oxidative stress, and re-sensitized resistant cells to cisplatin.\",\n      \"method\": \"shRNA knockdown, cell viability, invasion/migration assays, Western blotting, signaling pathway analysis\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — pathway placement by KD with defined phenotype, single lab, moderate mechanistic follow-up\",\n      \"pmids\": [\"31783581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Protein-protein interaction analysis revealed that GPX4 exerts its biological role through regulation of a GSS/GSR complex and downstream GGT family proteins; AFC-induced inhibition of this GPX4-GSS/GSR-GGT axis reduced glutathione synthesis and triggered ferroptosis in NSCLC cells.\",\n      \"method\": \"qPCR, protein-protein interaction analysis, cell proliferation and apoptosis assays, flow cytometry\",\n      \"journal\": \"International journal of medical sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — interaction identified by computational PPI analysis, limited direct biochemical validation of GSS complex\",\n      \"pmids\": [\"33746607\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"α-Hederin destroys the GSS/GSH/GPX2 axis in NSCLC by downregulating GSS expression, thereby suppressing glutathione synthesis, collapsing the GSH redox system, and inducing ferroptosis and apoptosis in vitro and in vivo.\",\n      \"method\": \"Proteomics, metabolomics, high-throughput sequencing, in vitro and in vivo cancer models\",\n      \"journal\": \"Biomedicine & pharmacotherapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multi-omic orthogonal methods in single lab establishing GSS as key node in ferroptosis pathway\",\n      \"pmids\": [\"35398749\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Gss is expressed primarily in pachytene spermatocytes, and conditional knockout of Gss in germ cells (using Stra8-Cre) causes age-dependent male infertility via ferroptosis in the testis. In young knockout mice, compensatory GPX4 upregulation prevents ROS accumulation; in aged mice, GPX4 declines and ALOX15 increases, leading to lipid peroxidation and testicular ferroptosis, disrupting meiosis and acrosome formation. Intraperitoneal GSH or ferrostatin-1 rescued fertility.\",\n      \"method\": \"Conditional Gss knockout (Stra8-Cre), fertility assays, immunofluorescence, ROS/lipid peroxidation assays, ferroptosis inhibitor rescue (GSH, Fer-1), Western blotting\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO with specific cellular phenotype, multiple orthogonal methods, mechanistic rescue experiments\",\n      \"pmids\": [\"38114454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Two fetal siblings with compound heterozygous GSS variants (missense p.Arg267Gln and a 2.4 kb intragenic deletion causing out-of-frame exon 3 deletion) exhibited severe GSS deficiency with multiple congenital anomalies. RNA-seq showed near-monoallelic expression and NMD of the deletion allele; elevated 5-oxoproline in amniotic fluid confirmed disruption of the gamma-glutamyl cycle.\",\n      \"method\": \"Genome sequencing, RNA-seq on brain tissue, amniotic fluid metabolite analysis (5-oxoproline measurement)\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — molecular characterization of mutant alleles with functional metabolic readout, single case series\",\n      \"pmids\": [\"39221916\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Age-related DNA methylation-mediated suppression of GSS in bone marrow mesenchymal stem cells (BMSCs) reduces glutathione synthesis and impairs osteoblast differentiation independently of substrate (cysteine) availability, constituting an upstream metabolic lesion in age-related osteoporosis. Exosome-mediated delivery of GSH to aged bone rescued osteogenic function.\",\n      \"method\": \"DNA methylation analysis, GSS expression analysis in aged BMSCs, cysteine supplementation experiments, CXCR4-exosome GSH delivery in vivo, osteogenesis assays\",\n      \"journal\": \"Bioactive materials\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epigenetic mechanism identified with functional rescue, single lab\",\n      \"pmids\": [\"41674552\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Metformin inhibits hypertrophic scar fibroblast proliferation and induces ferroptosis by downregulating RRM2, which in turn suppresses GSS expression, impairing glutathione synthesis, indirectly reducing GPX4, and leading to peroxide accumulation (RRM2/GSS/GPX4 axis).\",\n      \"method\": \"In vitro and in vivo (rabbit ear) fibrosis models, Western blotting, RRM2 knockdown, ferroptosis markers\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic and pharmacological perturbation with defined pathway placement, in vivo validation\",\n      \"pmids\": [\"41619824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"LncRNA HCG18 acts as a ceRNA to sponge miR-30a-5p, increasing RRM2 expression, which directly upregulates GSS to increase glutathione synthesis and confer ferroptosis resistance in hepatocellular carcinoma.\",\n      \"method\": \"Colony formation assay, xenograft mouse model, luciferase reporter, RRM2 overexpression/knockdown, GSS expression analysis\",\n      \"journal\": \"International journal of biological sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ceRNA axis validated in vitro and in vivo, RRM2-GSS link demonstrated by direct regulation experiment\",\n      \"pmids\": [\"40303288\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GSS (glutathione synthetase) catalyzes the final ATP-dependent step in glutathione biosynthesis; its transcription is regulated by the CNC-bZIP factor Nrf1 and by age-related DNA methylation, and its expression is controlled upstream by RRM2 (via the HCG18/miR-30a-5p/RRM2 axis); GSS-dependent GSH production is essential for male fertility (protecting spermatocytes from ferroptosis via a GPX4-compensatory mechanism), bone homeostasis, and resistance to ferroptosis in multiple cell types, with loss-of-function mutations disrupting the gamma-glutamyl cycle and causing hemolytic anemia, 5-oxoprolinuria, and developmental defects.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GSS (glutathione synthetase) catalyzes the ATP-dependent ligation of γ-glutamylcysteine and glycine in the final step of glutathione (GSH) biosynthesis, and its activity—rather than substrate availability—is rate-limiting for GSH production in multiple cell types [PMID:41674552]. GSS expression is transcriptionally regulated by Nrf1 via the antioxidant response element [PMID:10601325], positioned downstream of RRM2 [PMID:41619824, PMID:40303288], and epigenetically silenced by age-dependent promoter DNA methylation [PMID:41674552]. Loss of GSS function triggers accumulation of reactive oxygen species, lipid peroxidation, and ferroptosis, as demonstrated by conditional germ-cell knockout leading to age-dependent spermatocyte death rescued by exogenous GSH or ferrostatin-1 [PMID:38114454]. Biallelic loss-of-function mutations in GSS cause glutathione synthetase deficiency, a Mendelian disorder characterized by 5-oxoprolinuria, metabolic acidosis, and hemolytic anemia [PMID:29340523, PMID:39221916].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the genomic identity of GSS as a single-copy gene on chromosome 20q11.2 provided the foundation for subsequent mutation analysis and disease gene mapping.\",\n      \"evidence\": \"Somatic cell hybrid analysis, in situ hybridization, and Southern blotting with GSS cDNA\",\n      \"pmids\": [\"8825653\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Promoter structure and transcriptional regulation were not characterized\",\n        \"No functional studies linking locus to enzyme activity in vivo\"\n      ]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying Nrf1 as a transcriptional regulator of GSS placed the gene within the antioxidant response element pathway and explained how cells coordinately upregulate glutathione biosynthetic enzymes under oxidative stress.\",\n      \"evidence\": \"Nrf1 knockout mouse fibroblasts showing reduced GSH, enhanced oxidant sensitivity, and decreased GSS expression\",\n      \"pmids\": [\"10601325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Nrf2 or other transcription factors also regulate GSS was not resolved\",\n        \"Direct promoter binding by Nrf1 at the GSS locus was not demonstrated\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstrating that splice-site mutations can abolish GSS protein and enzyme activity expanded the known mutational spectrum of glutathione synthetase deficiency beyond missense/nonsense changes.\",\n      \"evidence\": \"RT-PCR sequencing, enzyme activity assay, and immunoblotting in fibroblasts from patients lacking coding-region mutations\",\n      \"pmids\": [\"14635114\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Quantitative genotype-phenotype correlation across mutation classes was not established\",\n        \"Functional rescue experiments were not performed\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of compound heterozygous GSS mutations causing neonatal glutathione synthetase deficiency with 5-oxoprolinuria confirmed GSS as the causal gene and linked complete enzymatic loss to the severe clinical phenotype.\",\n      \"evidence\": \"DNA sequencing, enzyme activity assay, and clinical biochemistry in a neonatal case\",\n      \"pmids\": [\"29340523\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single case report; genotype-phenotype spectrum across many patients remains incomplete\",\n        \"No in vitro reconstitution of mutant enzyme activity\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Conditional germ-cell knockout of Gss established that GSS-dependent GSH synthesis is essential to prevent ferroptosis in spermatocytes, revealing an age-dependent vulnerability linked to declining compensatory GPX4 expression.\",\n      \"evidence\": \"Stra8-Cre conditional Gss knockout mice with ROS, lipid peroxidation, GPX4/ALOX15 markers, and pharmacological rescue (GSH, ferrostatin-1)\",\n      \"pmids\": [\"38114454\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether other tissues show similar age-dependent ferroptotic vulnerability upon GSS loss is unknown\",\n        \"The mechanism by which GPX4 compensation declines with age was not defined\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Multi-omic profiling showed that pharmacological disruption of the GSS/GSH/GPX2 axis induces ferroptosis in NSCLC cells, positioning GSS as a druggable node in cancer redox defense.\",\n      \"evidence\": \"Proteomics, metabolomics, and high-throughput sequencing in α-hederin-treated NSCLC models in vitro and in vivo\",\n      \"pmids\": [\"35398749\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct target engagement between α-hederin and GSS was not demonstrated\",\n        \"Biochemical reconstitution of the GSS/GPX2 axis was not performed\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that age-related DNA methylation of the GSS promoter suppresses GSS expression and that cysteine supplementation cannot compensate established GSS enzymatic activity—not substrate supply—as the rate-limiting step for GSH synthesis in aging bone marrow mesenchymal stem cells.\",\n      \"evidence\": \"DNA methylation analysis, BMSC osteogenic differentiation assays, GSH measurement, cysteine supplementation failure, and exosome-mediated GSH rescue in aged mice\",\n      \"pmids\": [\"41674552\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether GSS promoter methylation is a general aging mechanism across tissues is unclear\",\n        \"Specific methyltransferases responsible were not identified\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"RNA-seq and genomic analysis of novel GSS variants (missense and intragenic deletion with NMD) in a fetal case confirmed disruption of the γ-glutamyl cycle and demonstrated near-monoallelic expression from the missense allele.\",\n      \"evidence\": \"Genome sequencing, RNA-seq on fetal brain, amniotic fluid 5-oxoproline measurement\",\n      \"pmids\": [\"39221916\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional impact of the p.Arg267Gln missense variant on enzyme kinetics was not biochemically characterized\",\n        \"Whether prenatal 5-oxoproline measurement can serve as a reliable diagnostic biomarker needs broader validation\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Placing GSS downstream of RRM2 in a ferroptosis-regulatory signaling axis (RRM2→GSS→GSH→GPX4) defined how non-canonical regulators control the glutathione pathway to modulate ferroptosis sensitivity in fibrotic and cancer contexts.\",\n      \"evidence\": \"Gene knockdown/overexpression of RRM2 and GSS, GSH/GPX4 measurement, ferroptosis assays in hypertrophic scar fibroblasts and HCC xenografts\",\n      \"pmids\": [\"41619824\", \"40303288\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The mechanism by which RRM2 directly regulates GSS expression (transcriptional vs. post-transcriptional) is undefined\",\n        \"RRM2–GSS regulation relies largely on expression correlation; direct biochemical evidence is lacking\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis for how disease-associated GSS mutations impair catalysis, whether tissue-specific epigenetic programs differentially regulate GSS across aging organs, and the direct molecular mechanism linking RRM2 to GSS transcription remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No crystal structure of human GSS with disease-associated mutations has been reported in this literature\",\n        \"Tissue-specific epigenetic regulation of GSS beyond BMSCs is unexplored\",\n        \"Direct RRM2-to-GSS regulatory mechanism is not biochemically defined\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [0, 2, 3, 8]},\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 3, 5, 6]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [3, 5, 7, 10]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 3, 6]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NRF1\",\n      \"GPX4\",\n      \"RRM2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"Glutathione synthetase (GSS) catalyzes the ATP-dependent ligation of γ-glutamylcysteine and glycine in the final step of de novo glutathione (GSH) biosynthesis, and its activity is rate-limiting for cellular redox homeostasis, ferroptosis resistance, and the γ-glutamyl cycle. GSS transcription is positively regulated by the CNC-bZIP factor Nrf1 [PMID:10601325] and by RRM2 (itself controlled via the HCG18/miR-30a-5p ceRNA axis) [PMID:40303288, PMID:41619824], and is suppressed by age-related DNA methylation in bone marrow mesenchymal stem cells, contributing to impaired osteogenesis [PMID:41674552]. Conditional germ-cell knockout in mice demonstrates that GSS-derived GSH is essential for male fertility, with loss triggering age-dependent testicular ferroptosis that is initially compensated by GPX4 upregulation but ultimately leads to lipid peroxidation, meiotic arrest, and acrosome defects [PMID:38114454]. Loss-of-function mutations in humans—including splice-site and intragenic deletions—cause glutathione synthetase deficiency with 5-oxoprolinuria, hemolytic anemia, and severe congenital anomalies [PMID:14635114, PMID:39221916].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Establishing the genomic context of GSS: mapping to a single-copy gene at chromosome 20q11.2 set the stage for mutation analysis in glutathione synthetase deficiency.\",\n      \"evidence\": \"Somatic cell hybrid and in situ hybridization with a GSS cDNA probe\",\n      \"pmids\": [\"8825653\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Promoter and regulatory elements of the GSS locus were not characterized\",\n        \"No disease-causing mutations had yet been mapped to this locus\"\n      ]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identifying the first transcriptional regulator of GSS: Nrf1 knockout fibroblasts showed reduced GSS expression, depleted GSH, and heightened oxidant sensitivity, establishing Nrf1 as a master upstream activator of the glutathione biosynthetic pathway.\",\n      \"evidence\": \"Nrf1-null mouse fibroblasts with gene expression analysis, GSH quantification, and oxidant challenge\",\n      \"pmids\": [\"10601325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether Nrf1 binds the GSS promoter directly or acts through intermediary factors was not resolved\",\n        \"Contribution of Nrf2 versus Nrf1 to GSS regulation was not delineated\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defining splice-site mutations as a major disease mechanism: patients without coding-exon mutations were shown to harbor splice defects that ablated GSS protein and enzymatic activity, broadening the mutational spectrum of glutathione synthetase deficiency.\",\n      \"evidence\": \"RT-PCR, immunoblot, and enzyme activity assay in patient fibroblasts\",\n      \"pmids\": [\"14635114\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Genotype–phenotype correlations across the full spectrum of GSS mutations were not established\",\n        \"No structural explanation for residual activity in partial-loss alleles\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Placing GSS as a central node in ferroptosis resistance: multiple studies in cancer cells showed that pharmacological or genetic suppression of GSS collapses the GSH/GPX axis and induces ferroptosis, linking GSS activity directly to lipid peroxide detoxification.\",\n      \"evidence\": \"Multi-omic profiling (proteomics, metabolomics, sequencing) in NSCLC models treated with α-hederin; pathway analysis of GPX4–GSS/GSR–GGT axis\",\n      \"pmids\": [\"35398749\", \"33746607\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The GPX4–GSS/GSR complex interaction (PMID:33746607) relied on computational PPI analysis without direct biochemical validation\",\n        \"Whether GSS enzymatic activity or protein scaffolding drives the ferroptosis phenotype was not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating an essential, non-redundant role of GSS in male germ cells: conditional Gss knockout in spermatocytes caused age-dependent ferroptosis, with early GPX4 compensation eventually failing, proving that GSS-derived GSH is indispensable for spermatogenesis and acrosome biogenesis.\",\n      \"evidence\": \"Conditional knockout (Stra8-Cre) in mice with fertility testing, lipid peroxidation assays, and rescue by exogenous GSH and ferrostatin-1\",\n      \"pmids\": [\"38114454\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which GPX4 is initially upregulated to compensate for GSS loss is unknown\",\n        \"Whether somatic Sertoli-cell GSH contributes to paracrine germ-cell protection was not tested\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Expanding the clinical genetics of severe GSS deficiency: compound heterozygous fetal cases with a novel intragenic deletion showed near-monoallelic expression due to NMD and confirmed 5-oxoproline accumulation as a prenatal biomarker of γ-glutamyl cycle disruption.\",\n      \"evidence\": \"Genome sequencing, RNA-seq on fetal brain, amniotic fluid metabolite measurement\",\n      \"pmids\": [\"39221916\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural consequences of the p.Arg267Gln missense on enzyme stability or dimerization were not modeled\",\n        \"Only two siblings studied; broader genotype–phenotype correlations remain limited\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defining upstream regulatory axes that converge on GSS: RRM2 was identified as a direct positive regulator of GSS expression, itself modulated by the lncRNA HCG18/miR-30a-5p ceRNA circuit (in HCC) and by metformin-mediated suppression (in fibroblasts), positioning GSS as the effector node linking proliferative signaling to glutathione-dependent ferroptosis resistance.\",\n      \"evidence\": \"Luciferase reporter, RRM2 overexpression/knockdown, xenograft models, and in vivo rabbit ear fibrosis models\",\n      \"pmids\": [\"40303288\", \"41619824\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether RRM2 regulates GSS transcriptionally or post-transcriptionally was not fully resolved\",\n        \"Independence of the RRM2–GSS axis from Nrf1/Nrf2 signaling is untested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linking epigenetic silencing of GSS to age-related bone loss: DNA methylation-mediated GSS suppression in aged BMSCs impaired osteoblast differentiation independently of cysteine availability, identifying GSS as an upstream metabolic lesion in osteoporosis.\",\n      \"evidence\": \"DNA methylation and expression analysis in aged BMSCs, cysteine supplementation controls, CXCR4-exosome GSH delivery rescue in vivo\",\n      \"pmids\": [\"41674552\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific CpG sites mediating age-dependent GSS silencing were not mapped\",\n        \"Whether DNMT inhibitors can restore GSS expression and bone formation in vivo is untested\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of disease-causing GSS mutations, the relative contributions of Nrf1 versus Nrf2 versus RRM2 to tissue-specific GSS regulation, and whether GSS has non-catalytic roles (e.g. protein scaffolding) in ferroptosis signaling complexes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of human GSS with bound substrates or disease-associated mutant forms\",\n        \"Tissue-specific transcriptional regulation hierarchy (Nrf1 vs Nrf2 vs RRM2) not systematically compared\",\n        \"Potential non-enzymatic functions of GSS protein remain unexplored\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [1, 2, 5, 6, 7, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 5, 6, 8, 9, 10]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [5, 6, 9]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"NRF1\",\n      \"GPX4\",\n      \"RRM2\",\n      \"GSR\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}